Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 14%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is positioned for long-term success due to its strong leadership in the virtual healthcare industry, its innovative and expanding services through both organic growth and acquisitions, and its focus on cost management. While its near-term revenue growth may be impacted by fluctuations in its business segments and changes in healthcare insurance policies, the company's strong financials and consistent focus on providing value to its customers make it an attractive investment opportunity.

Bears say

Teladoc Health is facing near-term financial uncertainty due to a slowdown in revenue growth, driven in part by the BetterHelp segment. As the company transitions to generating more profitable growth, there are potential upside catalysts, but the path forward remains uncertain. In addition, competition in all markets could hamper Teladoc's economic returns. However, the company's unique virtual care platform and expansion into new markets, such as primary care, provide long-term growth potential. Given the current challenges, a cautious approach is warranted, with a price target of $9.00 based on 10x CY26E Integrated Care adjusted EBITDA ex SBC.

Teladoc (TDOC) has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 14% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Buy based on their latest research and market trends.

According to 14 analysts, Teladoc (TDOC) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.